May 13, 2025
by Roman Kasianov
News
Valinor Discovery, a San Francisco-based startup, has launched from stealth with a focus on simulating how patients might respond to …
May 13, 2025
by Roman Kasianov
News
The company’s second Phase 1b/2 trial of LP-184 within a month will test the AI-developed small molecule in patients with …
May 13, 2025
by Roman Kasianov
News
OpenAI has released HealthBench, an open-source benchmark developed with 262 physicians across 60 countries to evaluate large language models (LLMs) in …
Insilico Medicine has filed again for an IPO on the Hong Kong Stock Exchange (HKEX), marking its third attempt following …
May 12, 2025
by Roman Kasianov
News
Toronto-based Intrepid Labs has emerged from stealth with $11 million in total funding to commercialize its autonomous drug formulation platform, …
A research team at Fujita Health University has developed a precision genome-editing approach to modulate levels of mutant mitochondrial DNA …
Khondrion, a clinical-stage biotech company focused on primary mitochondrial disease (PMD), has secured up to €5M in Innovation Credit from …
Iktos, a company developing AI and robotic technologies for medicinal chemistry and small molecule drug design, has expanded its collaboration …
May 9, 2025
by Roman Kasianov
News
At the 2025 Annual Meeting of the American Association for Cancer Research (AACR)—a major international conference focused on cancer science …
Benchling is expanding its collaboration with Moderna, which is now adopting the platform across its broader research organization. The rollout …
May 7, 2025
by Roman Kasianov
News
Milan-based startup ReportAId has raised €2.2 million in pre-seed funding to develop its AI platform aimed at converting unstructured medical …
May 7, 2025
by Roman Kasianov
News
North Bristol NHS Trust has been named the first European reference site for FUJIFILM Healthcare’s SYNAPSE Pathology system, marking a …